Citadel Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.7M Sell
152,900
-68,400
-31% -$4.93M ﹤0.01% 3037
2025
Q4
$14.1M Buy
221,300
+156,200
+240% +$9.63M ﹤0.01% 2782
2025
Q3
$4.1M Buy
65,100
+23,300
+56% +$1.63M ﹤0.01% 4709
2025
Q2
$3.12M Sell
41,800
-68,400
-62% -$5.37M ﹤0.01% 4912
2025
Q1
$9.71M Buy
110,200
+71,000
+181% +$6.7M ﹤0.01% 2885
2024
Q4
$3.58M Sell
39,200
-16,400
-29% -$1.68M ﹤0.01% 4530
2024
Q3
$6.22M Sell
55,600
-46,100
-45% -$4.61M ﹤0.01% 3602
2024
Q2
$9.96M Buy
101,700
+23,500
+30% +$2.33M ﹤0.01% 2775
2024
Q1
$7.84M Sell
78,200
-9,200
-11% -$809K ﹤0.01% 3277
2023
Q4
$7.85M Buy
87,400
+21,700
+33% +$1.73M ﹤0.01% 3160
2023
Q3
$5.04M Buy
65,700
+22,000
+50% +$1.83M ﹤0.01% 3629
2023
Q2
$3.66M Sell
43,700
-11,600
-21% -$943K ﹤0.01% 4129
2023
Q1
$4.66M Sell
55,300
-52,200
-49% -$4.48M ﹤0.01% 3935
2022
Q4
$8.75M Sell
107,500
-29,800
-22% -$2.4M ﹤0.01% 3009
2022
Q3
$9.76M Sell
137,300
-19,800
-13% -$1.78M ﹤0.01% 2808
2022
Q2
$14.1M Buy
157,100
+22,900
+17% +$2.37M ﹤0.01% 2245
2022
Q1
$15M Buy
134,200
+30,100
+29% +$3.53M ﹤0.01% 2367
2021
Q4
$12.6M Buy
104,100
+52,800
+103% +$5.87M ﹤0.01% 2684
2021
Q3
$5.17M Sell
51,300
-74,700
-59% -$8.24M ﹤0.01% 4234
2021
Q2
$14.7M Buy
126,000
+58,300
+86% +$7M ﹤0.01% 2505
2021
Q1
$7.46M Buy
67,700
+4,800
+8% +$521K ﹤0.01% 3459
2020
Q4
$6.31M Sell
62,900
-44,700
-42% -$4.14M ﹤0.01% 3291
2020
Q3
$8.41M Sell
107,600
-17,700
-14% -$1.33M ﹤0.01% 2494
2020
Q2
$8.73M Buy
125,300
+24,600
+24% +$1.55M ﹤0.01% 2385
2020
Q1
$4.69M Buy
100,700
+18,100
+22% +$1.16M ﹤0.01% 2798
2019
Q4
$6.55M Sell
82,600
-20,700
-20% -$1.59M ﹤0.01% 2738
2019
Q3
$7.63M Sell
103,300
-4,200
-4% -$301K ﹤0.01% 2554
2019
Q2
$8.37M Sell
107,500
-10,000
-9% -$760K ﹤0.01% 2397
2019
Q1
$8.92M Buy
117,500
+16,200
+16% +$1.29M ﹤0.01% 2222
2018
Q4
$7.41M Sell
101,300
-3,400
-3% -$271K ﹤0.01% 2259
2018
Q3
$10M Buy
104,700
+33,100
+46% +$3.28M ﹤0.01% 2094
2018
Q2
$7.16M Sell
71,600
-15,500
-18% -$1.64M ﹤0.01% 2308
2018
Q1
$9.2M Buy
87,100
+38,600
+80% +$3.9M 0.01% 1811
2017
Q4
$4.49M Sell
48,500
-25,900
-35% -$2.35M ﹤0.01% 2601
2017
Q3
$6.73M Buy
74,400
+800
+1% +$68.1K 0.01% 1978
2017
Q2
$6.18M Sell
73,600
-7,100
-9% -$572K 0.01% 1896
2017
Q1
$6.52M Sell
80,700
-27,500
-25% -$2.16M 0.01% 1778
2016
Q4
$8.14M Sell
108,200
-18,300
-14% -$1.32M 0.01% 1534
2016
Q3
$8.56M Sell
126,500
-42,000
-25% -$2.82M 0.01% 1500
2016
Q2
$11.4M Sell
168,500
-22,600
-12% -$1.66M 0.01% 1142
2016
Q1
$13.8M Buy
191,100
+86,300
+82% +$5.65M 0.02% 980
2015
Q4
$7.08M Buy
104,800
+17,200
+20% +$1.2M 0.01% 1529
2015
Q3
$5.67M Sell
87,600
-39,500
-31% -$2.92M 0.01% 1818
2015
Q2
$10.4M Buy
127,100
+40,900
+47% +$3.15M 0.01% 1451
2015
Q1
$5.97M Sell
86,200
-18,300
-18% -$1.32M 0.01% 1857
2014
Q4
$7.93M Buy
104,500
+14,200
+16% +$1.12M 0.01% 1581
2014
Q3
$7.3M Buy
90,300
+45,300
+101% +$3.78M 0.01% 1642
2014
Q2
$3.93M Sell
45,000
-21,200
-32% -$1.84M ﹤0.01% 2052
2014
Q1
$5.71M Buy
66,200
+11,300
+21% +$926K 0.01% 1660
2013
Q4
$4.43M Sell
54,900
-15,900
-22% -$1.23M 0.01% 1784
2013
Q3
$5.51M Sell
70,800
-15,000
-17% -$1.16M 0.01% 1517
2013
Q2
$6.01M Buy
+85,800
New +$5.98M 0.01% 1401

Other funds holding EMN

Citadel Advisors's EMN Position: Q1 2026 in Review

Citadel Advisors reduced its Eastman Chemical (EMN) stake by 82% in Q1 2026, selling an estimated $78.7M and leaving 241,755 shares worth $18.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2421.

Citadel Advisors first reported a position in EMN in Q2 2013 and has held it in 50 quarters since. The position peaked at $136M in Q1 2015. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Citadel Advisors held 241,755 shares of Eastman Chemical worth $18.5M as of Q1 2026.
  • Citadel Advisors sold 1,091,337 Eastman Chemical shares in Q1 2026, an estimated $78.7M.
  • Eastman Chemical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2421 holding.
  • Citadel Advisors first reported a position in Eastman Chemical in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Eastman Chemical position peaked at $136M in Q1 2015.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.